The Food and Drug Authority has confirmed that it is constantly monitoring alternative generic drugs to ensure their efficacy, quality and bioequivalence with the innovative drug.The drug factory is inspected and quality is monitored after registration approval.
The authority explained that there is a misunderstanding that generic medicines are less effective than innovative medicines, but the reality is that registered (alternative) generic medicines offer the same medical efficacy, but the price of generic medicines is often much higher. low, because they do not require research or marketing costs.
He stressed that the difference between them can be in color, flavor and price, but they are identical in terms of active ingredient, concentration, dosage and method of use, explaining that the innovative drugs have a legal protection period of 17 to 20 years. , during which only the innovative company can produce the same drug.
Watching #food_and_medicine Generic generics are constantly used to ensure their efficacy, quality and bioequivalence with the innovative drug. pic.twitter.com/I0RWkVzfyC
– Food and Pharmaceutical Authority (@Saudi_FDA) October 31, 2022
